Atlas Trials

Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma

Clinical trial NCT05182957 · RECRUITING

Trial details

NCT number
NCT05182957
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed/Refractory Peripheral T-cell Lymphoma
Start date
2020-01-01
Primary completion
2023-12-15
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.